Analysis of tobacco-specific nitrosamines in the common smokeless tobacco Afzal in Oman

Sultan Qaboos University Medical Journal

Volumn 16, Issue 1, 2016, Pages e20-e26

  Al Mukhaini, Nawal ^a   Ba Omar, Taher ^a   Eltayeb, Elsadig A ^a   Al Shehi, Aisha A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Carcinogenesis; Liquid chromatography; Nitrosamines; Oman; Smokeless tobaccos; Tandem mass spectrometry

Indexed keywords

EID: 84956661108     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: 10.18295/squmj.2016.16.01.005     Document Type: Article

References (34)

1. United States Department of Health and Human Services. The health consequences of using smokeless tobacco: A report of the Advisory Committee to the Surgeon General. From: www.profiles.nlm.nih.gov/ps/access/NNBBFC.pdf Accessed: Oct 2015.
2. Brunnemann KD, Hoffmann D. Chemical composition of smokeless tobacco products. In: National Cancer Institute. Smoking and tobacco control monograph 2: Smokeless tobacco or health- An international perspective. From: www.cancercontrol.cancer.gov/brp/tcrb/monographs/2/m2_3.pdf Accessed: Oct 2015.
3. Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTekR standard. Harm Reduct J 2011; 8:11. doi: 10.1186/1477-7517-8-11.
4. International Agency for Research on Cancer. IARC monograph 89: Smokeless tobacco and some tobaccospecific N-nitrosamines. From: www.monographs.iarc.fr/ENG/Monographs/vol89/ Accessed: Oct 2015.
5. International Agency for Research on Cancer. IARC monographs volume 37: Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. From: www.monographs.iarc.fr/ENG/Monographs/vol1-42/mono37.pdf Accessed: Oct 2015.
6. Clayton PM, Cunningham A, van Heemst JD. Quantification of four tobacco-specific nitrosamines in cigarette filter tips using liquid chromatography-tandem mass spectrometry. Anal Methods 2010; 2:1085–94. doi: 10.1039/b9ay00306a.
7. Pauli G. History of the U.S. Food and Drug Administration. From: www.fda.gov/downloads/aboutfda/whatwedo/history/oralhistories/selectedoralhistorytranscripts/ucm390423.pdf/ Accessed: Oct 2015.
8. Lawler TS, Stanfill SB, Zhang L, Ashley DL, Watson CH. Chemical characterization of domestic oral tobacco products: Total nicotine, pH, unprotonated nicotine and tobaccospecific N-nitrosamines. Food Chem Toxicol 2013; 57:380–6. doi: 10.1016/j.fct.2013.03.011.
9. World Health Organization. WHO Study Group on Tobacco Product Regulation: Report on the scientific basis of tobacco product regulation. From: www.who.int/tobacco/global_inter action/tobreg/publications/tsr_955/en/ Accessed Oct 2015.
10. Idris AM, Nair J, Ohshima H, Friesen M, Brouet I, Faustman EM, et al. Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 1991; 12:1115–18. doi: 10.1093/carcin/12.6.1115.
11. Hoffmann D, Djordjevic MV, Fan J, Zang E, Glynn T, Connolly GN. Five leading U.S. commercial brands of moist snuff in 1994: Assessment of carcinogenic N-nitrosamines. J Natl Canc Inst 1995; 87:1862–9. doi: 10.1093/jnci/87.24.1862.
12. Al-Mukhaini NM, Ba-Omar T, Eltayeb E, Al-Shehi A. Characterisation of nicotine and cancer-enhancing anions in the common smokeless tobacco Afzal in Oman. Sultan Qaboos Univ Med J 2015; 15:e469–76. doi: 10.18295/squmj.2015.15.04.005.
13. Al-Mukhaini N, Ba-Omar T, Eltayeb E, Al-Shehi A. Determination of heavy metals in the common smokeless tobacco Afzal in Oman. Sultan Qaboos Univ Med J 2014; 14:e349–55.
14. Borgerding MF, Bodnar JA, Curtin GM, Swauger JE. The chemical composition of smokeless tobacco: A survey of products sold in the United States in 2006 and 2007. Regul Toxicol Pharmacol 2012; 64:367–87. doi: 10.1016/j.yrtph.2012.09.003.
15. Smokeless Tobacco Sub-Group Technical Report. CORESTA Reference Products 2010 Analysis, February 2014. From: www.coresta.org/Reports/STS-CTR_2010-4CRP-Analysis.pdf Accessed: Oct 2015.
16. Centers for Disease Control and Prevention. Notice regarding requirement for annual submission of the quantity of nicotine contained in the smokeless tobacco products manufactured, imported, or packaged in the United States. Fed Regist 1999; 64:14086–96.
17. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: Occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985; 6:295–303. doi: 10.1093/carcin/6.2.295.
18. Andersen RA, Burton HR, Fleming PD, Hamilton-Kemp TR. Effect of storage conditions on nitrosated, acylated, and oxidized pyridine alkaloid derivatives in smokeless tobacco products. Canc Res 1989; 49:5895–900.
19. Chamberlain WJ, Chortyk OT. Effects of curing and fertilization on nitrosamine formation in Bright and Burley tobacco. Beiträge zur Tabakforschung 1992; 15:87–92. doi: 10.2478/cttr-2013-0625.
20. Shi H, Wang R, Bush LP, Zhou J, Yang H, Fannin N, et al. Changes in TSNA contents during tobacco storage and the effect of temperature and nitrate level on TSNA formation. J Agric Food Chem 2013; 61:11588–94. doi: 10.1021/jf404813m.
21. Osterdahl B, Jansson C, Paccou A. Decreased levels of tobaccospecific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem 2004; 52:5085–8. doi: 10.1021/jf049931a.
22. Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC. Tobaccospecific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 2005; 116:16–19. doi: 10.1002/ijc.20966.
23. Stanfill SB, Connolly GN, Zhang L, Jia TL, Henningfield J, Richter P, et al. Global surveillance of oral tobacco products: Total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 2011; 20:e2. doi: 10.1136/tc.2010.037465.
24. Hearn BA, Renner CC, Ding YS, Vaughan-Watson C, Stanfill SB, Zhang L, et al. Chemical analysis of Alaskan Iq’mik smokeless tobacco. Nicotine Tob Res 2013; 15:1283–8. doi: 10.1093/ntr/nts270.
25. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008; 10:1773–82. doi: 10.1080/14622200802443544.
26. Bartsch H, Spiegelhalder B. Environmental exposure to N-nitroso compounds (NNOC) and precursors: An overview. Eur J Cancer Prev 1996; 5:11–17.
27. Balbo S, James-Yi S, Johnson CS, O’Sullivan MG, Stepanov I, Wang M, et al. (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats. Carcinogenesis 2013; 34:2178–83. doi: 10.1093/carcin/bgt162.
28. Yuan JM, Gao YT, Murphy SE, Carmella SG, Wang R, Zhong Y, et al. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res 2011; 71:6749–57. doi: 10.1158/0008-5472.CAN-11-0209.
29. Murphy SE, Carmella SG, Idris AM, Hoffmann D. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol Biomarkers Prev 1994; 3:423–8.
30. Hecht SS, Carmella SG, Murphy SE. Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines. Biomed Environ Sci 1991; 4:93–103.
31. Idris AM, Prokopczyk B, Hoffmann D. Toombak: A major risk factor for cancer of the oral cavity in Sudan. Prev Med 1994; 23:832–9. doi: 10.1006/pmed.1994.1141.
32. Ahmed HG, Mahgoob RM. Impact of toombak dipping in the etiology of oral cancer: Gender-exclusive hazard in the Sudan. J Canc Res Ther 2007; 3:127–30. doi: 10.4103/0973-1482.34696.
33. Digard H, Gale N, Errington G, Peters N, McAdam K. Multianalyte approach for determining the extraction of tobacco constituents from pouched snus by consumers during use. Chem Cent J 2013; 7:55. doi: 10.1186/1752-153X-7-55.
34. ® limits for undesired components. From: www.swedishmatch.com/en/Snus-and-health/GOTHIATEK/GOTHIATEKstandard/ Accessed: Oct 2015.